On 2025-05-14, Climb Bio, Inc. (CLYM) announced earnings per share of $-0.31 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.15.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.18 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.15 | $-0.31 |
| 2025-03-25 | 2024-12-31 | $-0.15 | $-0.13 |
| 2024-11-12 | 2024-09-30 | -- | $-0.13 |
| 2024-08-14 | 2024-06-30 | -- | $-1.81 |
| 2024-05-15 | 2024-03-31 | -- | $-0.06 |
| 2024-03-28 | 2023-12-31 | -- | $-0.13 |
| 2023-11-14 | 2023-09-30 | -- | $-0.15 |
| 2023-08-10 | 2023-06-30 | -- | $-0.19 |
| 2023-05-11 | 2023-03-31 | $-0.28 | $-0.84 |
| 2023-03-06 | 2022-12-31 | $-0.44 | $-0.29 |
| 2022-11-14 | 2022-09-30 | $-0.42 | $-0.37 |
| 2022-08-15 | 2022-06-30 | $-0.47 | $-0.52 |
| 2022-05-16 | 2022-03-31 | $-0.57 | $-0.50 |
| 2022-03-07 | 2021-12-31 | $-0.70 | $-0.40 |
| 2021-11-08 | 2021-09-30 | $-1.17 | $-0.70 |
| 2021-09-13 | 2021-06-30 | $-2.30 | $-3.11 |